Sex differences in methamphetamine seeking in rats: Impact of oxytocin

Psychoneuroendocrinology

Volumn 38, Issue 10, 2013, Pages 2343-2353

  Cox, Brittney M ^a   Young, Amy B ^a   See, Ronald E ^a   Reichel, Carmela M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Methamphetamine; Oxytocin; Progressive ratio; Reinstatement; Self administration; Sex differences

Indexed keywords

METHAMPHETAMINE; OXYTOCIN; SUCROSE; YOHIMBINE;

ANALYTICAL PARAMETERS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SEEKING BEHAVIOR; ESTRUS CYCLE; FEMALE; LEARNING; MALE; METHAMPHETAMINE DEPENDENCE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE RATIO; RAT; REINFORCEMENT; REINSTATEMENT; SEX DIFFERENCE;

METHAMPHETAMINE; OXYTOCIN; PROGRESSIVE RATIO; REINSTATEMENT; SELF-ADMINISTRATION; SEX DIFFERENCES;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; ESTROUS CYCLE; FEMALE; MALE; METHAMPHETAMINE; OXYTOCIN; RATS; RATS, LONG-EVANS; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SEX CHARACTERISTICS;

EID: 84883892083     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.05.005     Document Type: Article

References (50)

1. Anker J.J., Carroll M.E. Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend. 2010, 107:264-267.
2. Back S.E., Brady K.T., Jackson J.L., Salstrom S., Zinzow H. Gender differences in stress reactivity among cocaine-dependent individuals. Psychopharmacology (Berl) 2005, 180:169-176.
3. Baracz S.J., Rourke P.I., Pardey M.C., Hunt G.E., McGregor I.S., Cornish J.L. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behav. Brain Res. 2012, 228:185-193.
4. Baskerville T.A., Allard J., Wayman C., Douglas A.J. Dopamine-oxytocin interactions in penile erection. Eur. J. Neurosci. 2009, 30:2151-2164.
5. Baskerville T.A., Douglas A.J. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci. Ther. 2010, 16:e92-e123.
6. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 1996, 23:39-51.
7. Burkett J.P., Young L.J. The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) 2012, 224:1-26.
8. Caldwell J.D., Walker C.H., Pedersen C.A., Barakat A.S., Mason G.A. Estrogen increases affinity of oxytocin receptors in the medial preoptic area-anterior hypothalamus. Peptides 1994, 15:1079-1084.
9. Carson D.S., Cornish J.L., Guastella A.J., Hunt G.E., McGregor I.S. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010, 58:38-43.
10. Carson D.S., Hunt G.E., Guastella A.J., Barber L., Cornish J.L., Arnold J.C., Boucher A.A., McGregor I.S. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict. Biol. 2010, 15:448-463.
11. Cicero T.J., Davis L.A., LaRegina M.C., Meyer E.R., Schlegel M.S. Chronic opiate exposure in the male rat adversely affects fertility. Pharmacol. Biochem. Behav. 2002, 72:157-163.
12. Coirini H., Schumacher M., Flanagan L.M., McEwen B.S. Transport of estrogen-induced oxytocin receptors in the ventromedial hypothalamus. J. Neurosci. 1991, 11:3317-3324.
13. Dluzen D.E., Liu B. Gender differences in methamphetamine use and responses: a review. Gend. Med. 2008, 5:24-35.
14. Dumont G.J., Sweep F.C., van der Steen R., Hermsen R., Donders A.R., Touw D.J., van Gerven J.M., Buitelaar J.K., Verkes R.J. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc. Neurosci. 2009, 4:359-366.
15. Feltenstein M.W., Ghee S.M., See R.E. Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats. Drug Alcohol Depend. 2012, 121:240-246.
16. Feltenstein M.W., Henderson A.R., See R.E. Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology (Berl) 2011, 216:53-62.
17. Ghitza U.E., Gray S.M., Epstein D.H., Rice K.C., Shaham Y. The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology 2006, 31:2188-2196.
18. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
19. Greenwald M.K., Lundahl L.H., Steinmiller C.L. Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals. Psychopharmacology (Berl) 2013, 225:811-824.
20. Holtz N.A., Lozama A., Prisinzano T.E., Carroll M.E. Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone. Drug Alcohol Depend. 2012, 120:233-237.
21. Hser Y.I., Evans E., Huang Y.C. Treatment outcomes among women and men methamphetamine abusers in California. J. Subst. Abuse Treat. 2005, 28:77-85.
22. Kovacs G.L., Sarnyai Z., Barbarczi E., Szabo G., Telegdy G. The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity. Neuropharmacology 1990, 29:365-368.
23. Landgraf R., Ermisch A., Hess J. Indications for a brain uptake of labelled vasopressin and ocytocin and the problem of the blood-brain barrier. Endokrinologie 1979, 73:77-81.
24. Macdonald K., Macdonald T.M. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv. Rev. Psychiatry 2010, 18:1-21.
25. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 2002, 62:609-614.
26. McGregor I.S., Bowen M.T. Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm. Behav. 2012, 61:331-339.
27. McGregor I.S., Callaghan P.D., Hunt G.E. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?. Br. J. Pharmacol. 2008, 154:358-368.
28. McKay J.R., Rutherford M.J., Cacciola J.S., Kabasakalian-McKay R., Alterman A.I. Gender differences in the relapse experiences of cocaine patients. J. Nerv. Ment. Dis. 1996, 184:616-622.
29. Milesi-Halle A., McMillan D.E., Laurenzana E.M., Byrnes-Blake K.A., Owens S.M. Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats. Pharmacol. Biochem. Behav. 2007, 86:140-149.
30. Neumann I.D., Wigger A., Torner L., Holsboer F., Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J. Neuroendocrinol. 2000, 12:235-243.
31. Patchev V.K., Schlosser S.F., Hassan A.H., Almeida O.F. Oxytocin binding sites in rat limbic and hypothalamic structures: site-specific modulation by adrenal and gonadal steroids. Neuroscience 1993, 57:537-543.
32. Peters S., Slattery D.A., Flor P.J., Neumann I.D., Reber S.O. Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice. Addict. Biol. 2013, 18:66-77.
33. Qi J., Han W.Y., Yang J.Y., Wang L.H., Dong Y.X., Wang F., Song M., Wu C.F. Oxytocin regulates changes of extracellular glutamate and GABA levels induced by methamphetamine in the mouse brain. Addict. Biol. 2012, 17:758-769.
34. Qi J., Yang J.Y., Wang F., Zhao Y.N., Song M., Wu C.F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009, 56:856-865.
35. Rawson R.A., Gonzales R., Obert J.L., McCann M.J., Brethen P. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J. Subst. Abuse Treat. 2005, 29:67-74.
36. Reichel C.M., Chan C.H., Ghee S.M., See R.E. Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats. Psychopharmacology (Berl) 2012, 223:371-380.
37. Reichel C.M., See R.E. Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse. Psychopharmacology (Berl) 2010, 210:337-346.
38. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., Bartlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008, 199:109-117.
39. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 1996, 66:1-11.
40. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl) 1989, 98:408-411.
41. Roth M.E., Carroll M.E. Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology (Berl) 2004, 172:443-449.
42. Sarnyai Z., Babarczy E., Krivan M., Szabo G., Kovacs G.L., Barth T., Telegdy G. Selective attenuation of cocaine-induced stereotyped behaviour by oxytocin: putative role of basal forebrain target sites. Neuropeptides 1991, 19:51-56.
43. Sarnyai Z., Kovacs G.L. Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology 1994, 19:85-117.
44. Schindler C.W., Bross J.G., Thorndike E.B. Gender differences in the behavioral effects of methamphetamine. Eur. J. Pharmacol. 2002, 442:231-235.
45. Schumacher M., Coirini H., Pfaff D.W., McEwen B.S. Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors. Science 1990, 250:691-694.
46. See R.E., Waters R.P. Pharmacologically-induced stress: a cross-species probe for translational research in drug addiction and relapse. Am. J. Transl. Res. 2010, 3:81-89.
47. Shors T.J., Beylin A.V., Wood G.E., Gould E. The modulation of Pavlovian memory. Behav. Brain Res. 2000, 110:39-52.
48. Yahyavi-Firouz-Abadi N., See R.E. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol. Ther. 2009, 124:235-247.
49. Yen C.F., Chong M.Y. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr. Psychiatry 2006, 47:215-220.
50. Zhou L., Ghee S.M., Chan C., Lin L., Cameron M.D., Kenny P.J., See R.E. Orexin-1 receptor mediation of cocaine seeking in male and female rats. J. Pharmacol. Exp. Ther. 2012, 340:801-809.